BetterScholar BetterScholar
5
Role
Title
Level Year L/R
🐜 Clinical spectrum time course in non-Asian patients positive for anti-MDA5 antibodies.
97 auth. L. Cavagna, F. Meloni, A. Meyer, G. Sambataro, M. Belliato, E. De Langhe, I. Cavazzana, N. Pipitone, K. Triantafyllias, M. Mosca, S. Barsotti, G. Zampogna, A. Biglia, G. Emmi, M. de Visser, ... A. J. van der Kooi, P. Parronchi, S. Hirschi, J. D. da Silva, C. Scirè, F. Furini, M. Giannini, O. Martínez González, L. Damian, Y. Piette, V. Smith, Antonio Mera-Valera, J. Bachiller-Corral, Ivan Cabezas Rodriguez, A. Brandy-García, F. Maurier, J. Perrin, J. González-Moreno, U. Drott, C. Delbruck, A. Schwarting, E. Arrigoni, G. Sebastiani, A. Iuliano, C. Nannini, L. Quartuccio, A. B. Rodríguez Cambrón, M. Blázquez Cañamero, I. Villa blanco, G. Cagnotto, A. Pesci, F. Luppi, G. Dei, F. Romero Bueno, F. Franceschini, I. Chiapparoli, G. Zanframundo, S. Lettieri, L. De Stefano, M. Cutolo, A. Mathieu, M. Piga, S. Prieto-González, M. Moraes-Fontes, J. Fonseca, V. Jovaní, V. Riccieri, A. Santaniello, S. Montfort, David Bilocca, G. Erre, E. Bartoloni, R. Gerli, M. Monti, Hanns-Martin Lorenz, D. Sambataro, S. Bellando Randone, U. Schneider, C. Valenzuela, R. López-Mejías, J. Cifrián, M. Mejía, Monserrat-Ixchel Gonzalez Perez, S. Wendel, M. Fornaro, G. de Luca, G. Orsolini, M. Rossini, P. Dieudé, J. Knitza, S. Castañeda, R. Voll, J. Rojas-Serrano, A. Valentini, C. Vancheri, M. Matucci-Cerinic, E. Feist, V. Codullo, F. Iannone, J. Distler, C. Montecucco, M. González-Gay
4 2022
4
🐜
🐜 Idiopathic inflammatory myopathies and antisynthetase syndrome: contribution of antisynthetase antibodies to improve current classification criteria
7 auth. M. Greco, M. J. García de Yébenes, I. Alarcón, A. Brandy-García, Í. Rúa-Figueroa, E. Loza, ... L. Carmona
4 2019
4
🐜
🐬 IgA vasculitis and polymyalgia rheumatica induced by durvalumab
I. Casafont-Solé, M. Martínez-Morillo, J. Camins-Fàbregas, A. Brandy-García, A. Quer, T. Morán
3 2020
3
🐬
🐜 Antisynthetase antibodies in clinical laboratories: the importance of clinical correlation and indirect immunofluorescence. Response to: Comment on: ‘Idiopathic inflammatory myopathies and antisynthetase syndrome: contribution of antisynthetase antibodies to improve current classification criteria’
7 auth. M. Greco, M. J. García de Yébenes, I. Alarcón, A. Brandy-García, Í. Rúa-Figueroa, E. Loza, ... L. Carmona
2 2019
2
🐜
🐬 Interleukin-17–targeted treatment in patients with spondyloarthritis and associated cardiometabolic risk profile
R. Queiró, E. Aurrecoechea, S. Alonso Castro, I. Villa blanco, A. Brandy-García, R. Linge
1 2023
1
🐬